Lexaria Bioscience
LEXX • NASDAQ
Lexaria Bioscience is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Richard C. Christopher, with a market cap of $23.4M.
Market Cap$23.4M
Employees3.0
CEORichard C. Christopher
CountryCanada
Healthcare
Biotechnology
Next EarningsJul 13, 2026 · in 3 monthsQ2 2026
Financials
Lexaria Bioscience FAQ
Common questions about Lexaria Bioscience
Lexaria Bioscience is scheduled to report earnings for Q2 2026 on July 13, 2026. Analysts estimate revenue of $50.0K.
Lexaria Bioscience has approximately 3 employees.